BE869248A - Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie - Google Patents

Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie

Info

Publication number
BE869248A
BE869248A BE189484A BE189484A BE869248A BE 869248 A BE869248 A BE 869248A BE 189484 A BE189484 A BE 189484A BE 189484 A BE189484 A BE 189484A BE 869248 A BE869248 A BE 869248A
Authority
BE
Belgium
Prior art keywords
hyperglucagonemia
hyperglycemia
treatment
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
BE189484A
Other languages
English (en)
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of BE869248A publication Critical patent/BE869248A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BE189484A 1977-07-25 1978-07-25 Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie BE869248A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/818,379 US4118495A (en) 1977-07-25 1977-07-25 Method of treating hyperglucagonemia with 1,3-dioxo-1H-benz[de]-isoquinoline-2(3H)-acetic acid

Publications (1)

Publication Number Publication Date
BE869248A true BE869248A (fr) 1979-01-25

Family

ID=25225409

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189484A BE869248A (fr) 1977-07-25 1978-07-25 Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie

Country Status (4)

Country Link
US (1) US4118495A (fr)
JP (1) JPS5437833A (fr)
BE (1) BE869248A (fr)
ZA (1) ZA783846B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254109A (en) * 1979-11-08 1981-03-03 Ayerst, Mckenna & Harrison Inc. 1H-Benz[de]isoquinoline-2(3H)-acetic acid derivatives
US4254108A (en) * 1979-11-08 1981-03-03 Ayerst, Mckenna & Harrison Inc. Thioxo-1H-benz[de]isoquinoline-2(3H)-acetic acid derivatives and antidiabetic use thereof
US4598081A (en) * 1984-10-12 1986-07-01 Nauchno-Issledovatelsky Institut Endokrinologii I Obmena Veschestv 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
JPS5437833A (en) 1979-03-20
ZA783846B (en) 1979-07-25
US4118495A (en) 1978-10-03

Similar Documents

Publication Publication Date Title
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE884917A (fr) Agent pour le traitement de theilerioses et son application
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
BE876157Q (fr) Medicament pour le traitement de l'acne
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE881208A (fr) Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE873092A (fr) Composition pour le traitement de l'hypertension
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
BE885290A (fr) Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE869248A (fr) Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie
BE860992A (fr) Composition et tampon pour le traitement ou la prevention de l'acne et d'affections de la peau similaires
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis